Translocation of Intracellular CD24 Constitutes a Triggering Event for Drug Resistance in Breast Cancer

Scientists evaluated the phenotype switching associated with drug resistance in breast cancer cell lines and cell lineage obtained from Brazilian patients and highlighted the role of the cancer stem cell marker CD24 in the dynamics of cell plasticity and the acquirement of drug resistance.